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Konsm Ciry bfkwrrri 
r*gresstoo analysis, age a70 years. left ventricular ejection 
fraciion 540% and prior cornnary arlery bypass urgery 
wer8 awciated with an increased morlality rate during the 
f&w.“p pertnd. 
Percutaneous tran5luminal coronery angioplus,) a5 iniliully 
described t I) was a ,herapeu,ic option only il: the occ~~kuud 
patient with refrxtwy angma due ,o it proximal. non&i- 
tied, single discrete lesion in u single mior epicardxd core- 
nary orkry. As oper.ltur experience und angioplasty equip 
men, evolved. many ECB,CI~ litvralircd Ihc wlcclion crilcrw 
,o include palienlr w,h qnifican, ~knoses in muhiplc 
coronary arleries GISI. Mul,ivcsscl coronary angioplwy 
has been performed ut our inrfiwion ,hrou$hou, the lit\, 
and wniwl. ,ilthough repeat co&nary a&platy for 
rpstenosis or nen disease. or both. was performed in 38% 
of palienls. onI> 16% of pattents required bypass urgery. 
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decade. yet it remains a controverrial procedure because of 
uncer,;untw ahout snfcly and long.rerm efficacy. The pur- 
now of thk \,udy is ,o wxrd our entire evxncncc wilh 
k~hwxel curo&ry &iuplasty. Addilionally. we ha+c 
ewnwely fullowcd up the tircl 700 polienlr 10 determine 
the lung-term effectivenerr of ,he procedure. 
Methods 
Sludy palien& The rtudy group canskted of 3.186 pa- 
lien,< who had ckriw coronary angioplasly of two or three 
of the rhrcc major epicardial cownary \y~tems. This series 
UX\ comprwd of cunseanive multiver\rl angioplasly pro- 
cedure\ performed brtrvccn June I980 and January 1989. 
Elcclive Icfi main corowry angiaplasty wa excluded. The 
mean age wi!, 60 year* (mngc ?? 10 921 and ?.543 (ROO) were 
men. Two and three vcs2el cornnary angioplasty was per- 
formed rn 2.399 and 787 patients. respecrivcly. 
Complete long-term fol!ow-up data were available fur the 
6nt 700 patients who underwenr multivesxl coronxy an- 
uioulastv. In this erouu. 549 patients (78%) underwent twn _. 
vessel angioplasty and ISI (22%) three-vecrel angiaplasty. 
The study was designed to evaluate long-term ou!come after 
inrtia!ly successful multivessel angioplasty. and thus patients 
were excluded from the follow-up study ifthe procedure was 
complicated by an acute Q wave myocardial infarction. 
coronary artery bypass graft surgery or death during Ihe 
initial hospilalizalion. Patients in whom coronary angio. 
plasty had been performed previously were also excluded. 
l’oroneryanginplaslypracedure. Percutaneoustranslumi- 
nal coronary angioplasty war performed using standard 
techniques as previously described 12). Our strategy has 
been to attempt complete revascularization by dilalion of all 
significant stenoses during a single procedure whenever 
possible, Generally. the most severe stenosis in the coronary 
artery subtending the largest amount of myocardium was 
dilated first. All patients were pretreated with aspirin 025 
rng three times daily). dipyridamole (75 mg three limes daily) 
and a calcium channel antagonist. On arrival in the catheter- 
ization laboratory. patients received lidocaine (75 mg intro- 
venously). isosurbide dirdtrate (5 mg sublingually) and ve- 
rapamil (5 mg imrwenoualy). A dextran infusion was 
variably utilized depending on operator preference. At the 
beginning of the procedure an intravenous bolus injection of 
lO,COO U of heparin was given. followed by a 5.000 U bolus 
per hour during the procedure. 
A&r on,@oplasrv a continuous heparin infusion was 
administered for I8 to 24 h, with a target partial thrombo- 
plasrin time between 70 and 100 s. Geuerul!j. patients were 
continued on treatment with aspirin, dipyridamole and a 
calcium charnel blocker for 2 months. followed by aspirin 
alone thereafter. In recent years. dipyridamole was dircon- 
tinued at the tune of hospital discharge. 
Follow-up data. Prospective long-term follow-up data 
were ob;ained from mailed questionnaires, telephone inter- 
views and follow-up patient visits. This information was 
stored in a computer data base and updated periodically. 
Only one patient was lost to follow-up evaluation. 
Definitions. Multivessel disease was defined as ~70% 
stenosis in major vessels or branches in two or three of the 
major epicardial coronary systems. Dilation ofat least two of 
the major coronary systems qualified BL multivessel angio- 
plasty. Angioplasty of both an obtuse margins1 branch and 
the left circumflex coronary artery. or the left anterior 
descending and a diagonal branch or tandem lesions in the 
satr~e vessel was defined as a single vessel dilation and was 
excluded from this series unless angioplasty was also per- 
formed tn a second coronary system. 
Anw~prophic SIKWIJ war dcfinrd as reduction of the 
luminal diameter stenosis to 540% by visual assessment in 
multiple projections. Procedural success WBE defined as 
successful dilation of at leas1 two lesions in different coro- 
nary artery systems without major in-hospital complications, 
including Q wave myocardial infarction, coronary artery 
bypass graft surgery or death. Complete revascularization 
was considered as the absence of any lesion with ~50% 
luminal diameter stenosis in B nonbypassed major coronary 
artery or branch. Event-free survival was defined as the 
absence of death, 0 wave mvocardial infarction and core- 
nary bypass graft s&gery dur& the follow-up period. 
Statistics. Interval level data were compared by using 
Student’s I test and CatepiC data were evaluated with the 
chi-square test or Fisher exact test. All reported p values 
were two-tailed. Logistic regression analysis was used to 
identify varinbles independently predictive of in-hospital 
death. The multivariate odds ratio was calculated as the 
natural logarithm of the regression coefficient and reflected 
the independent risk of death associated with the presence of 
a specific variable when all other variables were held con- 
stant. The Cox regression analysis was used to evaluate 
variables affecting long-term and event-free survival. Sur- 
vival curves were constructed using the Kaplan-Meier actu- 
arial method. 
Results 
Patient characteristics (Table I). Multivessel coronary 
angioplasty was performed in 3.186 or 41% of the 7.729 total 
ckcriw coronary angioplasty procedures between June I980 
and January 1989. Throughout the study period, multivessel 
angioplasty accounted for a progressively larger proportion 
of the total elective angioplasty volume (Fig. I ). The baseline 
(Table 3). A mean of 3.6 lesions were ddaled pck patient. 
Angiographic success was achteved in IO.836 (Yh%‘r) 01 
11.336 lesions with allempled dilation. The angiographic 
success rab by specific coronary segment (Tnhle 2) ranged 
fmmm a high of 97% in the proximal and mid-M ;mkrmr 
descending coronary arkry and in r;lphenous vein hgpa\\ 
grafts lo a low of 93% in the obtuse mwginal branches of the 
left circumflex coronary artery. 
The preangioplarly characteristics of these 7tN patients are 
listed in Table I. In this group. 549 (7851 had coronary 
angioplasty of two major epicardial coronary rystems and 
151 (22%) had dilation of all three systems. 
Swvivat. Overall survival and event-free survival are 
depicted in Figure 2. Death during the follow-up period 
occurred in 80 patienls (II%). The actuark.; I and 5 year 
survival rates were 97% and 88%. respectively. Event-free 
survival rates at I and 5 years were YtYZ and 74%, respec- 
tively. Multivariare analysis (Fig. 3) identified age 270 
years. ejeclion fraction ~40% nod prior coronary artery 
bypw surgery as independently associated with long-term 
mortality. Long-term survival was not significantly different 
in patients with two versus three vessel coronary anery 
disease (Fig. 4). Although event-free survival (freedom from 
death. Q wave infarction and coronary bypass surgery1 was 
significantly better in patients with complete revascolariza- 
don (Fig. 5). the degree of revascularization did not affect 
Figure 3. Actuarial survival for patient< with a leb ventricular 
ejecrion fraction IEF) >4o% is significantly better then that far 
paknlr with an ejecoun frafkm r40%. 
Figure 4. Actuadal survival for patients \/ith two or three vessel 
coronary artery disaaw was no! signiticanrty dikrent. 
overall long-term survival. The 5 year survival rate was 8% 
and 88% for complete and incomplete revasctdarization. 
respectively. 
Repeat revascularizatian procedures. A total of 322 pa- 
dent3 (46%) underwent repeat revasculartration procedures 
during the follow-up period (41 patients required more than 
one r&at proced& Repeat coronary angioplasty was 
oerformed in 265 oatients (38%). inclodine 126 satients 
i 18%) with resten& only. 85 patient< (:?%)kith reStenosis 
and disease progression at sites not previously dilated and 54 
patients (8%) with new disease progression alone. Resteno- 
sis with or without disease progression at other sites resulted 
in repeat revascularization procedures in 227 patients (32%). 
During the follow-up period. I10 patients (16%) underwent 
coronary anery bypass grafl surgery. Repeat coronary an- 
gioplasty allowed 212 patients 00% of the entire group) to 
avoid coronary bypass surgery during the follow-up period. 
Actuarial analysis revealed that repeat revascularkuion 
Figure 5. Event-free survival lfreedam from death. Q wave infarc- 
tion and coronary bypass surgery) was significantly better in pa- 
tients with complele mv&xwlarization with mgioplwy. 
procedures (coronary anery bypass @I ~rgcry or repeat 
angioplasty) were required whhin 4 years in Wi of those 
with complete revascularization and 33% of thoqc with 
incomplete revascutarizalion (p = 0.03). Seventyone per- 
cent of patients with complete rcvasculariznlion rcmaintid 
Free of angina during the follow-up period compared with 
57% of those with incomplele revascularizidlon (p = 0.011. 
The spmpmmnfic srnm of he 700 pcrtirnrr at baseline 
sludy (before angioplastyl and at the end of the followup 
period is depicted in Table 5. Marked impmvement in the 
anginal paltern persisted ihmughout the follow-up period. 
Discussion 
As coronary atherosclerosis progresses in e~lenf and 
severity, the assochxed morbidity and mortality rates also 
increase (16.17). A majority of patients have dcvelopcd 
multivessel coronary artery disease by the time they present 
clinically with angica pectoris 118). Com~ry altery bypass 
surgery has been ducumenied (13,iOi K mprove the mor- 
tality rdte and palliale symptoms in patienis with three vessel 
coronary artery disease. However, because this procedure 
requires general aneahesia. a thoracotomy and cardiopul- 
monary bypass, it carries a relatively high incidence of 
attendant perioperative morbidity and mortality (19.21). 
Additionally, atherosclerotic disease progression in the na- 
tive coronary arteries as well as in saphenous vein bypass 
grafts remains a major problem. diminishing much of the 
conferred benefit within 7 to 10 years (21). Coronary angio- 
plalry has also been utilized as a means of rcvsscularizarion 
in parients with multivessel disease. Although the present 
study does not coinpare ihese two treatment options. it does 
document the safety and long-term effectiveners ofmultives- 
sel angioplasty. thereby laying the groundwork for random- 
ized trials comparing the relative merits and limitations of 
angioplasty and bypass surgery in patients with two or three 
diseased coronary arteries. 
Immediate re~lts al nn&ivessel angioplasty. The term 
“multivessel angioplarty” has been used in the past to 
describe different pal&t groups. In this series. only patients 
wh dkwx~ m two or more major coronary arteries are 
tncluded: patients wilh multivessel disease who underwent 
Gnglc +~el dilalion or those wilh mubilesion angioplasty in 
a cinElc coronary system were excluded. The present study 
dcmon~ates that multivessel coronary angiopla~ly can bc 
pcrfurmed with a high primary success rate 196%) and a law 
In-hocpllal moflality rate (1%). This in-hospital mortality 
rake ‘3 ac similar to the 0-W noted in our experience with 
clcctiYe \inplc vessel coronary angioplasty during the same 
pcnod IJ~IVXI~ wilh multivessel disease who experienced a 
complication during the dilation of the firsi artery attempted 
with qubsequenl abortion of Ihe procedure were classified as 
single ycc<el angioplasty patients, thus tomewhat artifacnt- 
ally Increasing monality and complication rabx in this 
group. Other complications. including myocardial infarction 
II.??) and need for urgent coronary artery bypass graft 
surgery tl’X1 were zncounlered infrequently with multiver- 
WI nngiopla>ty and at rates similar IO those seen with single 
WWI anginplasty. 
Long-term efiacy. The long-term outcome after multi- 
vessel coronary angioplasty in this series of 700 patients is 
encoumginp. At the end of the follow-up period, the condi- 
tion of S6?4 of patients with multivessel angioplasry re- 
mained improved (67% were asymptomatic and 19% had 
mild angina) and the 5 year survival rate was RBC/n. Not 
surprisingly. the major long-term liability of multivessel 
coronary angioplasty was the frequent need for subsequent 
revaacularira~ion procedures: these were required in nearly 
half of the patlrnts during the 54 month mean fol!%v-up 
period. The odds that reslenosis will nccur in at least one 
lesion increase as the number of sites dilated incre?ye !X;. 
Thus. restemna will be encounrercd more frequently in 
ml;lti!e?in? cnepared with single lesion angioplasty. Even- 
tual restenods requiring repeal angioplasty or coronary 
bypass snrgcry occuxed ia 3PX of the entire group aad 
accounted for 71% of the repeat revascularization prn~e- 
durcs. Despite this, S4A of patienls were able lo avoid 
coronary artery bypass surgery during a lon@term follow-up 
period after multivessel ayioplasly. 
The coronary dilator either did nor wtempr 10 or was 
unable to completely revascularize the diseased arteries in 
33% of patients. and this did compromise ihe long+erm 
effectiveness of ihe procedure in this subgroup. Recurrent 
angina1 symptoms and repeat revascularization procedures 
were seen more ofren in patients with incomplete revascu- 
larization. although long-term survival was similar to that in 
patients with complete revascularization. Previous reports 
have proposed “culprit lesion” angioplasly with incomplete 
revascularization as an &c&e option For palliation in some 
patients with multivessel coronary artery disease. Several 
sludies (B.lJ.IS.24~. including the prcsen! one. have dncu- 
mented a higher cardiac event rate in these patients. af- 
though this may in part be explained by baseline differences 
between the two groups (more diffuse and extensive disease 
in those patients with mcomplete revascularirationt. 
Limitations of the current study. This is a nonrandomizcd 
retrospccfive study with all of the inherent limitations of 
such a trial. The study cohort is a selected group and thus 
these results cannot be generalized to all patients with 
multivesse! disease. Furthermore. direct comparison with 
ciwious surgical results is not Dossible. Randomized trials 
&ch as the bypass Angioplast; Revascularizatian Investi- 
gation (BARI) and Emory Angioplasty Versus Surgery Trial 
(EAST) are currently in progress and will further define the 
roles of surgery and angiop!jsty in the treatment of patients 
with two and three vessel coronary artery disease. A multi- 
disciplinary approach should continue to evolve whereby 
effective revascularization is achieved. resulting in symptom 
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